Rhabdomyosarcoma of the cervix uteri

disease
On this page

Also known as CERMScervical rhabdomyosarcomarhabdomyosarcoma (disease) of uterine cervixuterine cervix rhabdomyosarcomauterine cervix rhabdomyosarcoma (disease)

Summary

Rhabdomyosarcoma of the cervix uteri (MONDO:0016282) is a disease. A subtype of rhabdomyosarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namerhabdomyosarcoma of the cervix uteri
Mondo IDMONDO:0016282
Orphanet213802
NCITC128048
SNOMED CT763408003
UMLSC4289809
MedGen927341
GARD0020494
Anatomy (UBERON)UBERON:0000002
Is cancer (heuristic)no

Also known as: CERMS · cervical rhabdomyosarcoma · rhabdomyosarcoma (disease) of uterine cervix · uterine cervix rhabdomyosarcoma · uterine cervix rhabdomyosarcoma (disease)

Disease family

This is a subtype of rhabdomyosarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmcancersarcomasoft tissue sarcomarhabdomyosarcomarhabdomyosarcoma of the cervix uteri

Related subtypes (19): orbit rhabdomyosarcoma, spindle cell rhabdomyosarcoma, liver rhabdomyosarcoma, central nervous system rhabdomyosarcoma, mediastinum rhabdomyosarcoma, rectum rhabdomyosarcoma, gallbladder rhabdomyosarcoma, ovary rhabdomyosarcoma, breast rhabdomyosarcoma, testis rhabdomyosarcoma, rhabdomyosarcoma with mixed embryonal and alveolar features, prostate rhabdomyosarcoma, embryonal rhabdomyosarcoma, alveolar rhabdomyosarcoma, vaginal rhabdomyosarcoma, uterine corpus rhabdomyosarcoma, pleomorphic rhabdomyosarcoma, oral rhabdomyosarcoma, rhabdomyosarcoma, embryonal, 2

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.